Category Matches
- 11β-HSD Inhibitor
- 5-a-reductase Inhibitors
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- a-Glucosidase Inhibitors
- ACE Inhibitors
- acetoxychaviol
- Acetyl-CoA Carboxylase Inhibitor
- Activin-like Kinase
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adrenal Hormones and Modulators
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- aflatoxin
- Androgen Receptor Modulators
- Androgen Synthesis Inhibitors
- Anesthetic
- Angiotensin II Inhibitors
- Anti-atherosclerotic
- Anti-inflammatory
- anti-inflammatory
- Anti-mitotics
- Anti-protozoal
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antimicrobial Peptides - Others
- Antimitotics
- Antimitotics
- Antiprogestogens
- Apitolisib
- Appetite Modulators
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- artemether
- Beta-Adrenergic Receptor Antagonists
- Blog Post
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Anesthetic
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Calcitonin
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- Captopril
- Cardiomodulatory
- CCK Receptor Antagonists
- CCK Release Inhibitors
- CCK Release Stimulators
- CCT-245737
- Class V (Other)
- clostomicin
- Compounds targeting DNA synthesis and repair
- Corticosteroids and Modulators
- Corticotropin Releasing Factor
- cryptotanshinone
- CYP17A1 Inhibitors
- Cytidine/Cytosine
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- diclofenac
- Dihydrofolate Reductase
- Dihydrofolate Reductase Inhibitors
- DNA and RNA Synthesis Inhibitors
- DNA Crosslinking and Alkylating Agents
- Dopamine Receptor Inhibitors
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- Eicosanoid Inhibitors
- Endothelin Receptor Antagonists
- Ergosterol Inhibitors
- Estrogen Receptor Inhibitors
- etoposide
- eukaryotic initiation factor (PERK)
- EZH2 Histone Methyltransferase
- Factor Xa Inhibitors
- fexofenadine
- Furans - Other nucleic acid inhibitors
- GABA - Anesthetic
- Gastric Inhibitory Peptide
- Gastrointestinal Motility Modulators
- Ginkgolides and other Ginkgo-related Compounds
- Ginsenosides and Other Ginseng-related Compounds
- Glucocorticoids - Other Therapies
- GlyR - Anesthetic
- guanine nucleotide exchange factor
- HDAC inhibitor
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- Hs578T
- Hs578Ts(i)8
- huntington's
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Immunomodulatory
- Immunostimulatory
- Inhibitors of other enzymes
- Integrase Inhibitors
- Ion Channels - Anesthetic
- ITF-2357
- K+ Channels - Anesthetic
- Kinesin Inhibitors
- Leukotriene Receptor Antagonists
- M2 Protein Inhibitors
- mAChR - Anesthetic
- Marine Toxins
- Melatonin Receptors - Analgesics
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Anxiolytic
- Melatonin Receptors - Hypnotics
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- Microtubule Polymerization/Depolymerization Inhibitors
- mTOR
- Muscarininc Acetylcholine Receptor Inhibitors
- mycotoxin
- Mycotoxins
- Na+ Channels - Anesthetic
- nAChR - Anesthetic
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- Neuraminidase Inhibitors
- Neuromodulatory
- Neurotoxins
- Nitrovasodilators
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Anesthetic
- NMDA Receptors - Neurodegenerative Diseases
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- odontoblast
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- Other Analogs
- Other Compounds
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Diuretics
- Other Hormones and Modulators
- Other Ion Channels - Analgesics
- Other Ion Channels - Anesthetic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Ion Channels - Anxiolytic
- Other Ion Channels - Cognition Enhancing
- Other Ion Channels - Sedatives
- Other Lipid-lowering Compounds
- Other Neurotransmitters
- Other NSAID
- Other Nucleic Acid Inhibitors
- Other Products
- Other Targets
- Other Therapies
- Others
- Others - Antibacterial
- Others - Antidiabetic
- Others - Antithrombotic
- Others - Cell Membrane Modifiers
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- outofstock
- Oxytocin
- parthenolide
- pentoxifylline
- Phytoestrogens
- phytosterol
- Profens
- Progestogens/Progestins
- propofol
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- ritonavir
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Analgesics
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Anxiolytic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- Sex steroids and Modulators
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Anxiolytic
- Sigma Receptors - Cognition Enhancing
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- sofosbuvir
- sofosbuvir
- Somatostatin Agonists
- Soy Isoflavones
- Stem Cell Modulators
- Steroids Hormones and Modulators
- streptogramins
- Therapies for Respiratory Diseases and Allergy Management
- Thrombin Inhibitors
- Thromboxane Receptor Antagonists
- Thyroid Hormones and Modulators
- Tocolytics
- togaviridae
- Top Menu
- TOPK
- Topoisomerase
- Topoisomerase Inhibitors
- tosufloxacin
- Transcription Factor Modifiers
- trichothecenes
- Trk Receptors - Cognition Enhancing
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Anesthetic
- tryptophan
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- USP40 Taxol Impurities - Semisynthetic
- Vasodilatory
- Viral Fusion and Entry Inhibitors
- xanthene
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β Cell Proliferation Activator
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
- Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- O9497Oxytocin
Endogenous neuropeptide hormone, involved in social recognition and intimacy ...
≥95% - I5414Indapamide
Thiazide-like diuretic; Kv7.1 and minK K+ channel blocker.
≥98% - C0175Carbetocin Acetate
Peptide, oxytocin analog; potential OXTR agonist.
≥95% - Z6269Z-Pro-D-Leu
Peptide fragment of oxytocin.
≥95% - LKT earns MBE Certification from the National Minority Supplier Development CouncilAs of October 12th, 2016, LKT Laboratories has earned its MBE certification from...
- Differentiating Embryonic Stem Cells with DorsomorphinIn 2008, Yu et al. identified a compound that dorsalizes structures in growing z...
- A7657Atosiban Acetate
Peptide, alters uterine contractility; V1/2 and OXTR antagonist.
≥95% - G4485[Ala19]-Glucagon-like Peptide II, rat
Peptide hormone, GLP-2 derivative; GLP2 agonist.
≥95% - G4484Glucagon-like Peptide II, rat
Endogenous peptide hormone, involved in intestinal function; GLP2 agonist.
≥95% - G4483Glucagon-like Peptide II, human
Endogenous peptide hormone, involved in intestinal function; GLP2 agonist.
≥95% - G4482Glucagon-like Peptide I (7-37)
Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and...
≥95% - G4481Glucagon-like Peptide I Amide (7-36), human
Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and...
≥95% - Rosiglitazone for Neuroinflammatory AbnormalitiesGulf War Illness is a chronic disorder brought on by exposure to sand storms, pr...
- New Product Spotlight: InhibitorsA 83-01 (LKT Product: A001001) A 83-01 is an inhibitor of ALK-5 (activin recepto...
- H9614Hydrochlorothiazide
Thiazide diuretic; NCCT inhibitor, carbonic anhydrase I inhibitor.
≥98% - S0400SB-431542
ALK4/5/7 (activin-like) inhibitor, TGF-β inhibitor.
≥98% - DNMT and HDAC Inhibition Block the Rise of Tumor Growth in Cancer Stem-like CellsA study published in 2015 found that breast cancer stem cells are intrinsically ...
- Sulforaphane suppresses tumor development in triple-negative breast cancerTriple-negative breast cancer (TNBC), so named for its lack of expression of the...
- G6400Glycylglutamine
Endogenous dipeptide, beta-endorphin derivative.
≥95%